You are here: Industry Insights > NHS

News List

NHS to undergo ‘ambitious’ tech overhaul pharmatimes
May 28, 2019
Matt Hancock, health secretary, has announced major improvements to general practice IT and more support for NHS Trusts to improve cyber security, as part of a new “ambitious tech overhaul”.
Biogen’s SMA drug Spinraza to be available on NHS pharmaceutical-technology
May 22, 2019
The UK’s National Health Service (NHS) has signed a managed access agreement to fund Biogen’s antisense oligonucleotide (ASO) Spinraza (nusinersen) for a limited time to ascertain its effectiveness as a treatment for 5q spinal muscular atrophy (SMA).
NHS England agree to pay for Biogen's $750,000 a year SMA treatment Spinraza pharmafile
May 16, 2019
NHS England has agreed to pay an undisclosed price for Biogen’s spinal muscle atrophy (SMA) treatment Spinraza.
£2m NHS investment into leadership development pharmatimes
May 12, 2019
NHS England has funded a £2 million programme to help boost system-wide leadership development.
NICE backs use of Ocrevus in primary progressive multiple sclerosis after Roche reaches pricing deal with NHS firstwordpharma
May 10, 2019
The National Institute for Health and Care Excellence issued final draft guidance Thursday recommending NHS reimbursement of Roche's Ocrevus (ocrelizumab) for treating primary progressive multiple sclerosis (PPMS) in adults.
Ocrevus finally available on NHS pharmatimes
May 09, 2019
After 21,000 people signed a charity petition, the first primary progressive multiple sclerosis (MS) drug has been made available on the NHS.
New report reveals priorities for local NHS research and innovation pharmatimes
May 09, 2019
Results of a 'landmark' consultation highlighting the priorities for local NHS research and innovation in different regional areas in England has now been published.
The price of access: Can the NHS afford Orkambi? pharmafile
May 09, 2019
The price of access: Can the NHS afford Orkambi?
NHS improvements to give patients faster access to pioneering treatments pharmatimes
May 09, 2019
NHS improvements to give patients faster access to pioneering treatments.
Five hepatitis C drugs to become available on the NHS pharmaceutical-technology
May 05, 2019
A deal signed by pharmaceutical companies AbbVie, Gilead Sciences and Merck Sharp and Dohme (MSD) will see five new hepatitis C drugs become available on the UK National Health Service (NHS).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page